Cell Reports (Mar 2024)

Serine/arginine-rich splicing factor 7 promotes the type I interferon response by activating Irf7 transcription

  • Haley M. Scott,
  • Mackenzie H. Smith,
  • Aja K. Coleman,
  • Kaitlyn S. Armijo,
  • Morgan J. Chapman,
  • Summer L. Apostalo,
  • Allison R. Wagner,
  • Robert O. Watson,
  • Kristin L. Patrick

Journal volume & issue
Vol. 43, no. 3
p. 113816

Abstract

Read online

Summary: Tight regulation of macrophage immune gene expression is required to fight infection without risking harmful inflammation. The contribution of RNA-binding proteins (RBPs) to shaping the macrophage response to pathogens remains poorly understood. Transcriptomic analysis reveals that a member of the serine/arginine-rich (SR) family of mRNA processing factors, SRSF7, is required for optimal expression of a cohort of interferon-stimulated genes in macrophages. Using genetic and biochemical assays, we discover that in addition to its canonical role in regulating alternative splicing, SRSF7 drives transcription of interferon regulatory transcription factor 7 (IRF7) to promote antiviral immunity. At the Irf7 promoter, SRSF7 maximizes STAT1 transcription factor binding and RNA polymerase II elongation via cooperation with the H4K20me1 histone methyltransferase KMT5a (SET8). These studies define a role for an SR protein in activating transcription and reveal an RBP-chromatin network that orchestrates macrophage antiviral gene expression.

Keywords